Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo

Eitemau Tebyg

• Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
  gan: Green, Michael R., et al.
  Cyhoeddwyd: (2010)
• Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas
  gan: Kluk, Michael J., et al.
  Cyhoeddwyd: (2012)
• CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas
  gan: Chen, Linfeng, et al.
  Cyhoeddwyd: (2020)
• Expression of Programmed Cell Death 1 Ligand 2 (PD-L2) is a Distinguishing Feature of Primary Mediastinal (Thymic) Large B-cell Lymphoma and Associated with PDCD1LG2 Copy Gain
  gan: Shi, Min, et al.
  Cyhoeddwyd: (2014)
• No Evidence for the JAK2 (V617F) or JAK2 Exon 12 Mutations in Primary Mediastinal Large B-Cell Lymphoma
  gan: Wu, David, et al.
  Cyhoeddwyd: (2009)